Drawbridge Health, a Thorne Company, secures FDA 510(K) clearance for at home blood sampling device, Nanodrop
Read Press Release

Drawbridge Secures FDA 510(K) Clearance for At-Home Blood Sampling Device Nanodrop

April 2, 2024

Drawbridge Health partners with University of Cambridge Researchers for use of OneDraw™️ Blood Collection Device in COVID-19 and Other Clinical Studies

December 3, 2020

Parexel Announces Strategic Collaboration with Synexa Life Sciences and Drawbridge Health for COVID-19 Clinical Serology Testing Solution

November 2, 2020

Drawbridge Health Announces Partnerships to Fuel Expansion in Japan

October 26, 2020

OneDraw™ Blood Collection Device Receives the Red Dot Award for Outstanding Medical Device Product Design

June 25, 2020

Drawbridge Health Announces CE Mark for the OneDraw™ A1C Test System

February 4, 2020

Drawbridge Health Announces Key Leadership Appointments

October 14, 2019

Drawbridge Health Receives FDA 510(k) Clearance for OneDraw™ A1C Test System

August 22, 2019

Strategic International Financing To Accelerate Blood Sampling Technology Innovation

July 24, 2019

New Research Data For Monitoring HbA1c Levels From Blood Collected By Innovative Blood Sampling Technology

June 7, 2019

We are pioneering the future of healthcare.
Join Us.

At Drawbridge Health we are on a mission to transform the blood draw experience and redefine healthcare standards. Please complete the form below to learn more about our innovative approach.

Are you a patient?

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Contact Us
News
Privacy
Legal
Copyright © 2024 Drawbridge Health, Inc. All rights reserved.